BioCentury
ARTICLE | Clinical News

Trimesta: Additional Phase II data

February 8, 2016 8:00 AM UTC

Synthetic Biologics said it will terminate its license and clinical trial agreements related to Trimesta with the Regents of the University of California based on analyses by 2 independent clinical r...